Cargando…
Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478391/ https://www.ncbi.nlm.nih.gov/pubmed/34553703 http://dx.doi.org/10.1097/CM9.0000000000001565 |
_version_ | 1784576046200258560 |
---|---|
author | Zhang, Xian-Wen Liu, Xiao-Xia Yong, Jun Wei, Li-Feng Ling, Chun-Yan Jin, Yu Chen, Yi-Ping Wang, Lin |
author_facet | Zhang, Xian-Wen Liu, Xiao-Xia Yong, Jun Wei, Li-Feng Ling, Chun-Yan Jin, Yu Chen, Yi-Ping Wang, Lin |
author_sort | Zhang, Xian-Wen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8478391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-84783912021-09-30 Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study Zhang, Xian-Wen Liu, Xiao-Xia Yong, Jun Wei, Li-Feng Ling, Chun-Yan Jin, Yu Chen, Yi-Ping Wang, Lin Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2021-09-20 2021-06-24 /pmc/articles/PMC8478391/ /pubmed/34553703 http://dx.doi.org/10.1097/CM9.0000000000001565 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Correspondence Zhang, Xian-Wen Liu, Xiao-Xia Yong, Jun Wei, Li-Feng Ling, Chun-Yan Jin, Yu Chen, Yi-Ping Wang, Lin Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study |
title | Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study |
title_full | Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study |
title_fullStr | Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study |
title_full_unstemmed | Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study |
title_short | Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study |
title_sort | association of anti-phospholipase a(2) receptor antibody with the efficacy of traditional chinese medicine (shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478391/ https://www.ncbi.nlm.nih.gov/pubmed/34553703 http://dx.doi.org/10.1097/CM9.0000000000001565 |
work_keys_str_mv | AT zhangxianwen associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy AT liuxiaoxia associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy AT yongjun associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy AT weilifeng associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy AT lingchunyan associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy AT jinyu associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy AT chenyiping associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy AT wanglin associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy |